Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A comprehensive, original take on Nvidia stock analysis: final. We break down growth drivers, valuation, risks, and p...
SoFi stock has faced a meaningful hurdle in 2026. This guide breaks down whether the decline represents a temporary s...
FOMO meets fundamentals. This guide breaks down how to evaluate a space tech megacap, manage risk, and decide if mont...
A surprising all-stock deal sent ON Semiconductor lower, wiping out gains from a strong AI data center narrative. Her...
Investing in niche AI infrastructure can offer outsized upside, but only with a plan. This article shows how buying P...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
Investors are buzzing about a potential shift in how Rocket Lab does business. This article delves into what a SpaceX...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...
Nebius Group stock down today has traders watching a broader AI data-center trend. This guide breaks down what moves ...
Peabody Energy stock 120% gains grab headlines, but what do they mean for real-world portfolios? This guide breaks do...